Patterns in Repeat Reinfections: Pre and Post Omicron Emergence
Authors:
Preprint
Abstract
Our understanding of SARS-CoV-2 reinfection patterns remains limited. We conducted a longitudinal study using Qatar’s national SARS-CoV-2 data from February 28, 2020 to June 11, 2023 to investigate incidence of reinfections both prior to and after omicron emergence. The latter analysis excluded individuals with pre-omicron infections. Before omicron introduction, the proportion of incident infections classified as reinfections gradually increased but remained minimal, reaching 1.8% just before omicron emerged. During the first omicron wave, this proportion reached 9.0%, a 5-fold increase. After the conclusion of the first omicron wave, the proportion of incident infections identified as reinfections rapidly increased, reaching 43.3% towards the end of the study. In the pre-omicron era, a total of 3,131 reinfections were documented, of which 99.6% were first reinfections and 0.4% were second reinfections. Meanwhile, a total of 20,962 reinfections were documented after an omicron primary infection of which 99.0% were first reinfections, 1.0% were second reinfections, and 0.01% were third reinfections. Reinfections were rare before omicron’s emergence but became widespread during the omicron era, including among individuals previously infected with omicron. Our findings may indicate accelerated viral evolution in the omicron era aimed at evading population immunity, but with minimal impact on COVID-19 severity, or potentially suggest immune imprinting effects that require further investigation.Keywords
This publication has 36 references indexed in Scilit:
- One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in QatarFrontiers in Cellular and Infection Microbiology, 2021
- BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in QatarNature Medicine, 2021
- Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in QatarInternational Journal of Infectious Diseases, 2021
- A Systematic Review of the Protective Effect of Prior SARS-CoV-2 Infection on Repeat InfectionEvaluation & the Health Professions, 2021
- mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in QatarNature Medicine, 2021
- COVID-19 (SARS-CoV-2) outbreak monitoring using wastewater-based epidemiology in QatarScience of The Total Environment, 2021
- SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacyeClinicalMedicine, 2021
- Characterizing the Qatar advanced-phase SARS-CoV-2 epidemicScientific Reports, 2021
- Two prolonged viremic SARS-CoV-2 infections with conserved viral genome for two monthsInfection, Genetics and Evolution, 2021
- Multiplexed RT-qPCR to screen for SARS-COV-2 B.1.1.7, B.1.351, and P.1 variants of concern v32021